
Ilaprazole sodium hydrate
CAS No. 2322264-11-7
Ilaprazole sodium hydrate( —— )
Catalog No. M37158 CAS No. 2322264-11-7
Ilaprazole (IY-81149) sodium hydrate is an orally active proton pump inhibitor that irreversibly inhibits H+/K+-ATPase in rabbit parietal cells with a dose-dependent IC50 of 6 μM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 74 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameIlaprazole sodium hydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionIlaprazole (IY-81149) sodium hydrate is an orally active proton pump inhibitor that irreversibly inhibits H+/K+-ATPase in rabbit parietal cells with a dose-dependent IC50 of 6 μM.
-
DescriptionIlaprazole (IY-81149) sodium hydrate is an orally active proton pump inhibitor. Ilaprazole sodium hydrate irreversibly inhibits H+/K+-ATPase in a dose-dependent manner with an IC50 of 6 μM in rabbit parietal cell preparation. Ilaprazole sodium hydrate is used for the research of gastric ulcers. Ilaprazole sodium hydrate is also a potent TOPK (T-lymphokine-activated killer cell-originated protein kinase) inhibitor.
-
In Vitro——
-
In VivoAnimal Model:Male SD rat (after pylorus ligation)Dosage:3, 10, 30 mg/kg Administration:Intraduodenally Result:The acid output and volume significantly inhibited by about 60% and 46% at 3 mg/kg were s, respectively. At 30 mg/kg, it showed 93% and 73% inhibition on acid output and volume, respectively.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetProton Pump
-
RecptorProton pump
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2322264-11-7
-
Formula Weight424.45
-
Molecular FormulaC19H21N4NaO4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=S(CC1=NC=CC(OC)=C1C)C2=NC3=C([N-]2)C=C(N4C=CC=C4)C=C3.[Na+].O.O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kwon D, et al. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo. Arzneimittelforschung. 2001;51(3):204-213. ?
molnova catalog



related products
-
Lansoprazole sodium
Lansoprazole sodium is a proton pump inhibitor (PPI) and a potent inhibitor of gastric acidity which is widely used in the therapy of gastroesophageal reflux and peptic ulcer disease.
-
Capmatinib 2HCl
INCB-28060(free base) is a novel, ATP-competitive inhibitor of c-MET kinase with an IC50 with 0.13 nM.
-
Ilaprazole sodium
Ilaprazole is a substituted benzimidazole prodrug with selective and irreversible proton pump inhibitor activity.